Lee's Pharmaceutical Holdings Limited (0950) Financial Statements

0 Followers

Lee's Pharmaceutical Holdings Limited Financial Overview

Lee's Pharmaceutical Holdings Limited's market cap is currently HK$659.50M. The company's EPS TTM is HK$0.042; its P/E ratio is 9.74; and it has a dividend yield of 2.92%. Lee's Pharmaceutical Holdings Limited is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 1.44B	HK$ 1.40B	HK$ 1.05B	HK$ 1.23B	HK$ 1.27B
Gross Profit	HK$ 729.56M	HK$ 753.36M	HK$ 551.31M	HK$ 770.75M	HK$ 806.28M
Operating Income	HK$ 61.48M	HK$ 113.14M	HK$ 43.55M	HK$ 76.56M	HK$ 1.98B
EBITDA	HK$ 217.13M	HK$ 260.87M	HK$ 193.05M	HK$ 229.06M	HK$ 2.13B
Net Income	HK$ 91.94M	HK$ 93.10M	HK$ 16.70M	HK$ 51.28M	HK$ 1.99B
Balance Sheet
Cash & Short-Term Investments	HK$ 349.90M	HK$ 216.84M	HK$ 171.00M	HK$ 189.30M	HK$ 277.53M
Total Assets	HK$ 3.46B	HK$ 2.62B	HK$ 2.89B	HK$ 2.78B	HK$ 3.64B
Total Debt	HK$ 310.27M	HK$ 227.30M	HK$ 204.14M	HK$ 163.49M	HK$ 267.14M
Net Debt	HK$ -39.63M	HK$ 10.45M	HK$ 33.14M	HK$ -25.81M	HK$ -10.39M
Total Liabilities	HK$ 1.56B	HK$ 1.07B	HK$ 930.07M	HK$ 939.50M	HK$ 1.25B
Stockholders' Equity	HK$ 2.05B	HK$ 1.65B	HK$ 2.04B	HK$ 1.92B	HK$ 2.46B
Cash Flow
Free Cash Flow	HK$ 101.35M	HK$ 34.45M	HK$ -49.63M	HK$ 69.81M	HK$ -160.04M
Operating Cash Flow	HK$ 332.90M	HK$ 242.01M	HK$ 110.08M	HK$ 283.63M	HK$ 210.68M
Investing Cash Flow	HK$ -235.76M	HK$ -190.23M	HK$ -145.22M	HK$ -256.05M	HK$ -370.28M
Financing Cash Flow	HK$ 35.58M	HK$ -1.96M	HK$ 13.44M	HK$ -128.60M	HK$ 60.97M

Currency in HKD

Lee's Pharmaceutical Holdings Limited Earnings and Revenue History

Income Statement >

Lee's Pharmaceutical Holdings Limited Debt to Assets

Balance Sheet >

Lee's Pharmaceutical Holdings Limited Cash Flow

Cash Flow >

Lee's Pharmaceutical Holdings Limited Forecast EPS vs Actual EPS

Earnings >